Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity

Yu Xuan Lyu*, Qiang Fu, Dominika Wilczok, Kejun Ying, Aaron King, Adam Antebi, Aleksandar Vojta, Alexandra Stolzing, Alexey Moskalev, Anastasia Georgievskaya, Andrea B. Maier, Andrea Olsen, Anja Groth, Anna Katharina Simon, Anne Brunet, Aisyah Jamil, Anton Kulaga, Asif Bhatti, Benjamin Yaden, Bente Klarlund PedersenBjörn Schumacher, Boris Djordjevic, Brian Kennedy, Chieh Chen, Christine Yuan Huang, Christoph U. Correll, Coleen T. Murphy, Collin Y. Ewald, Danica Chen, Dario Riccardo Valenzano, Dariusz Sołdacki, David Erritzoe, David Meyer, David A. Sinclair, Eduardo Nunes Chini, Emma C. Teeling, Eric Morgen, Eric Verdin, Erik Vernet, Estefano Pinilla, Evandro F. Fang, Evelyne Bischof, Evi M. Mercken, Fabian Finger, Folkert Kuipers, Frank W. Pun, Gabor Gyülveszi, Gabriele Civiletto, Garri Zmudze, Gil Blander, Harold A. Pincus, Joshua McClure, James L. Kirkland, James Peyer, Jamie N. Justice, Jan Vijg, Jennifer R. Gruhn, Jerry McLaughlin, Joan Mannick, João Passos, Joseph A. Baur, Joe Betts-LaCroix, John M. Sedivy, John R. Speakman, Jordan Shlain, Julia von Maltzahn, Katrin I. Andreasson, Kelsey Moody, Konstantinos Palikaras, Kristen Fortney, Laura J. Niedernhofer, Lene Juel Rasmussen, Liesbeth M. Veenhoff, Lisa Melton, Luigi Ferrucci, Marco Quarta, Maria Koval, Maria Marinova, Mark Hamalainen, Maximilian Unfried, Michael S. Ringel, Milos Filipovic, Mourad Topors, Natalia Mitin, Nawal Roy, Nika Pintar, Nir Barzilai, Paolo Binetti, Parminder Singh, Paul Kohlhaas, Paul D. Robbins, Paul Rubin, Peter O. Fedichev, Petrina Kamya, Pura Muñoz-Canoves, Rafael de Cabo, Richard G.A. Faragher, Rob Konrad, Roberto Ripa, Robin Mansukhani, Sabrina Büttner, Sara A. Wickström, Sebastian Brunemeier, Sergey Jakimov, Shan Luo, Sharon Rosenzweig-Lipson, Shih Yin Tsai, Stefanie Dimmeler, Thomas A. Rando, Tim R. Peterson, Tina Woods, Tony Wyss-Coray, Toren Finkel, Tzipora Strauss, Vadim N. Gladyshev, Valter D. Longo, Varun B. Dwaraka, Vera Gorbunova, Victoria A. Acosta-Rodríguez, Vincenzo Sorrentino, Vittorio Sebastiano, Wenbin Li, Yousin Suh, Alex Zhavoronkov*, Morten Scheibye-Knudsen*, Daniela Bakula*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

The recent unprecedented progress in ageing research and drug discovery brings together fundamental research and clinical applications to advance the goal of promoting healthy longevity in the human population. We, from the gathering at the Aging Research and Drug Discovery Meeting in 2023, summarised the latest developments in healthspan biotechnology, with a particular emphasis on artificial intelligence (AI), biomarkers and clocks, geroscience, and clinical trials and interventions for healthy longevity. Moreover, we provide an overview of academic research and the biotech industry focused on targeting ageing as the root of age-related diseases to combat multimorbidity and extend healthspan. We propose that the integration of generative AI, cutting-edge biological technology, and longevity medicine is essential for extending the productive and healthy human lifespan.

Original languageEnglish
Pages (from-to)12955-12976
Number of pages22
JournalAging
Volume16
Issue number20
DOIs
StatePublished - 2024

Funding

FundersFunder number
Li Ka Shing Faculty of Medicine, University of Hong Kong
Stockholms Universitet
University of Minnesota
Michael Antonov Foundation
Noaber Foundation
Insilico Medicine
Neye Foundation
Connor Fund
National Center for Advancing Translational Sciences UCLA Clinical and Translational Science Institute
Edythe Broad Center of Regenerative Medicine and Stem Cell Research
Max-Planck-Gesellschaft
Wenner-Gren Institute
Jonsson Cancer Center Foundation
National University Health System
USA 105Department of Molecular Biosciences
European Commission
VitaDao
Oppenheimer Program
University of Pittsburgh
Margaret E. Early Medical Research Trust
California Institute of Regenerative Medicine
Medicine Canada Inc.
Labs Inc.
Goethe-Universität Frankfurt am Main
European Research Council
National Institute on Aging
Centre for Physical Activity Research
Southern University of Science and Technology
National Eye InstituteR01AG063543, 1R43EY034403-01, U54AG076041, U54AG079754, ERC-2016-AdG-741966
TrygFonden20045, 125132, ID 101390
Natural Science Foundation of Shandong Province2021XDHZ082, ZR2023MH262
Irish Research CouncilIRCLA/2017/58
Fondation Santé19656
Lundbeck FoundationR324-2019-1492
Science Foundation Ireland19/FFP/6790
National Academy of MedicineAG82764, AG68667
Max Planck Institute for Molecular Biomedicine, Münster, Germany 107Healthspan CapitalCA 94530
California Institute for Regenerative Medicine-14096, ERC-2016AdG-741966
Tel Aviv UniversityCA 90001
National Institutes of HealthCA 94107, U01ES029519, P01AG017242, R01AG063404, R01AG 063389, R33AG061456, UG3CA268103, P01AG047200, U19AG056278, R01DK 117481, R01AG82708, R37AG013925, U01HL145560, R01AG068048, P01 AG062413, R01AG082105
Uddannelses- og Forskningsministeriet0238-00003B
Wellcome Trust220784/Z/20/Z
National University of SingaporeNUHSRO/2022/047/Startup/11
Indiana Clinical and Translational Sciences InstituteUL1TR000124
Novo Nordisk Foundation Challenge ProgrammeNNF17OC0027812
Nordea-fonden02-2017-1749
University of CaliforniaCA 90095

    Keywords

    • artificial intelligence
    • biotechnology
    • healthy longevity

    Fingerprint

    Dive into the research topics of 'Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity'. Together they form a unique fingerprint.

    Cite this